| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 原药(元) | 106,499,882.65 | 185,215,529.83 | 93,439,234.83 | 264,491,349.65 | 142,857,109.46 |
| 制剂(元) | 267,902,159.14 | 356,752,379.12 | 220,023,824.34 | 386,932,907.16 | 269,927,607.59 |
| 中间体(元) | 150,060,188.95 | 256,564,409.37 | 155,341,614.46 | 561,193,019.62 | 278,334,611.68 |
| 营业成本(元) | |||||
| 原药(元) | - | 207,336,474.51 | 104,041,567.33 | 250,299,091.38 | 130,001,974.23 |
| 制剂(元) | 128,000,561.42 | 188,661,174.40 | 108,366,439.62 | 191,467,791.44 | 125,848,317.11 |
| 中间体(元) | - | 233,200,662.23 | 137,802,064.77 | 466,121,014.10 | 229,685,402.53 |
| 毛利(元) | |||||
| 原药(元) | - | -22,120,944.68 | -10,602,332.50 | 14,192,258.27 | 12,855,135.23 |
| 制剂(元) | 139,901,597.72 | 168,091,204.72 | 111,657,384.72 | 195,465,115.72 | 144,079,290.48 |
| 中间体(元) | - | 23,363,747.14 | 17,539,549.69 | 95,072,005.52 | 48,649,209.15 |
| 毛利率(%) | |||||
| 原药(%) | - | -11.94 | -11.35 | 5.37 | 9.00 |
| 制剂(%) | 52.22 | 47.12 | 50.75 | 50.52 | 53.38 |
| 中间体(%) | - | 9.11 | 11.29 | 16.94 | 17.48 |
| 收入构成(%) | |||||
| 原药(%) | 20.31 | 23.19 | 19.93 | 21.81 | 20.67 |
| 制剂(%) | 51.08 | 44.68 | 46.93 | 31.91 | 39.06 |
| 中间体(%) | 28.61 | 32.13 | 33.14 | 46.28 | 40.27 |
| 毛利构成(%) | |||||
| 原药(%) | 0.00 | -13.06 | -8.94 | 4.66 | 6.25 |
| 制剂(%) | 100.00 | 99.27 | 94.15 | 64.14 | 70.08 |
| 中间体(%) | 0.00 | 13.80 | 14.79 | 31.20 | 23.66 |